Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials

Emmanuel Musisi, Adam J. Wyness, Sahar Eldirdiri, Evelin Dombay, Bariki A. Mtafya, Nyanda E. Ntinginya, Norbert Heinrich, Gibson S. Kibiki, Michael Hoelscher, Martin Boeree, Rob Aarnoutse, Stephen H. Gillespie, Wilber Sabiiti^*, PanACEA Consortium

^*Corresponding author for this work